25 November 2022: Articles
Two Pediatric Patients with Splanchnic Venous Thrombosis as a Complication of Acute Pancreatitis Successfully Treated with Low-Molecular-Weight Heparin and Rivaroxaban
Unusual clinical course, Unusual or unexpected effect of treatment
Shannon Capraro A , Melissa Acquazzino B , Mary Drake D , Chinenye R. Dike A*DOI: 10.12659/AJCR.937599
Am J Case Rep 2022; 23:e937599
Table 1. Pertinent laboratory values.
| Case 1 | Case 2 | |
|---|---|---|
| Hemoglobin A1c ( | 5.6 | 5.2 |
| Hemoglobin A1c ( | 5.4 | 11.8 |
| Fecal elastase (>200 ug/g); 2–4 months after episode | 273 | 284 |
| Fecal elastase (>200 ug/g) (12–24 months after hospitalization) | 460 | 18 |
| Admission Lipase (10–140 U/L) | >4000 | 5207 |
| Genetic testing | PRSS1 mutation, heterozygous CFTR mutation | Heterozygous CFTR mutation |
| Triglycerides (0–90 mg/dL) | 49 | 101 |
| IgG subclasses | Normal | Normal |
| PRSS1 – serine protease 1; CFTR – cystic fibrosis transmembrane conductance regulator; IgG – immunoglobin G; A1c – glycated hemoglobin. | ||